| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| I SHARES MSCI EMERGING MKT | 35,201 | 72,338 |
| I SHARES S&P BARRA GROWTH | 52,830 | 229,752 |
| I SHARES S&P 500 VALUE | 44,884 | 89,614 |
| I SHARES RUSSELL 2000 | 17,898 | 49,015 |
| BIOMARIN PHARMACEUTICAL | 60,300 | 87,690 |
| GUARDIAN 8 HOLDINGS | 50,000 | 1 |
| SUPERNUS PHARMACEUTICALS | 22,158 | 50,320 |
| MESOBLAST LTD SPON ADR | 78,690 | 106,125 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| QCA FIRST FUND IV, LLC | AT COST | 7,728 | 7,728 |
| HEALTHCARE ASSET NETWORK, INC. | FMV | 101,180 | 160,773 |
| QCA FIRST FUND VI, LLC | AT COST | 50,430 | 50,430 |
| SERENE LLC | AT COST | 243,239 | 243,239 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TRUST FEES | 194 | 194 | 0 | |
| ANNUAL REPORT FILING | 15 | 0 | 15 | |
| NON DEDUCTIBLE | 575 | 0 | 0 | |
| SERENE | 1,287 | 1,287 | 0 | |
| QCA VI | 3,492 | 3,492 | 0 | |
| OTHER COSTS | 7 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| QCA FIRST FUND IV | 551 | 551 | 551 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| AGENCY & INVESTMENT FEES | 3,381 | 3,381 | 0 | |
| BANK FEES | 0 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 176 | 176 | 0 |